A zinc sulphate-resistant acrodermatitis enteropathica patient with a novel mutation in SLC39A4 gene

12Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Acrodermatitis enteropathica (AE) is a rare autosomal recessive disorder of zinc deficiency due to an abnormal intestinal zinc transporter. It is characterized by the triad of acral dermatitis, alopecia, and diarrhoea. Once AE is correctly diagnosed, patients are treated with orally administered zinc sulphate. In some patients, relapses occur during adolescence, despite the regular treatment. Here, we discuss the clinical and molecular features of a 13-year-old adolescent girl with acrodermatitis enteropathica who was resistant to high-dose zinc sulphate therapy. We successfully treated the patient with zinc gluconate and vitamin C, and we detected a novel homozygous c.541_551dup (p.Leu186fsX38) mutation in the exon 3 of her SLC39A4 gene.

Cite

CITATION STYLE

APA

Kilic, M., Taskesen, M., Coskun, T., Gürakan, F., Tokatli, A., Sivri, H. S., … Küry, S. (2012). A zinc sulphate-resistant acrodermatitis enteropathica patient with a novel mutation in SLC39A4 gene. In JIMD Reports (Vol. 2, pp. 25–28). Springer. https://doi.org/10.1007/8904_2011_38

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free